Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors.

Saved in:
Bibliographic Details
Title: Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors.
Authors: Chimalakonda, Anjaneya1 (AUTHOR) anjaneya.chimalakonda@bms.com, Burke, James1 (AUTHOR), Cheng, Lihong1 (AUTHOR), Catlett, Ian1 (AUTHOR), Tagen, Michael1 (AUTHOR), Zhao, Qihong1 (AUTHOR), Patel, Aditya1 (AUTHOR), Shen, Jun1 (AUTHOR), Girgis, Ihab G.1 (AUTHOR), Banerjee, Subhashis1 (AUTHOR), Throup, John1 (AUTHOR)
Source: Dermatology & Therapy. Oct2021, Vol. 11 Issue 5, p1763-1776. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first